1 Study Coverage
    1.1 Psoriatic Arthritis Therapeutics Drug Product Introduction
    1.2 Market by Type
        1.2.1 Global Psoriatic Arthritis Therapeutics Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 NF Inhibitors
        1.2.3 Interleukin Inhibitors
        1.2.4 PDE4 Inhibitors
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Psoriatic Arthritis Therapeutics Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Psoriatic Arthritis Therapeutics Drug Sales Estimates and Forecasts 2017-2028
    2.2 Global Psoriatic Arthritis Therapeutics Drug Revenue Estimates and Forecasts 2017-2028
    2.3 Global Psoriatic Arthritis Therapeutics Drug Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Psoriatic Arthritis Therapeutics Drug Sales by Region
        2.4.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Region (2017-2022)
        2.4.2 Global Sales Psoriatic Arthritis Therapeutics Drug by Region (2023-2028)
    2.5 Global Psoriatic Arthritis Therapeutics Drug Revenue by Region
        2.5.1 Global Psoriatic Arthritis Therapeutics Drug Revenue by Region (2017-2022)
        2.5.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Manufacturers
        3.1.1 Global Top Psoriatic Arthritis Therapeutics Drug Manufacturers by Sales (2017-2022)
        3.1.2 Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Psoriatic Arthritis Therapeutics Drug in 2021
    3.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Manufacturers
        3.2.1 Global Psoriatic Arthritis Therapeutics Drug Revenue by Manufacturers (2017-2022)
        3.2.2 Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Psoriatic Arthritis Therapeutics Drug Revenue in 2021
    3.3 Global Psoriatic Arthritis Therapeutics Drug Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Psoriatic Arthritis Therapeutics Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Psoriatic Arthritis Therapeutics Drug Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Type
        4.1.1 Global Psoriatic Arthritis Therapeutics Drug Historical Sales by Type (2017-2022)
        4.1.2 Global Psoriatic Arthritis Therapeutics Drug Forecasted Sales by Type (2023-2028)
        4.1.3 Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2017-2028)
    4.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Type
        4.2.1 Global Psoriatic Arthritis Therapeutics Drug Historical Revenue by Type (2017-2022)
        4.2.2 Global Psoriatic Arthritis Therapeutics Drug Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2017-2028)
    4.3 Global Psoriatic Arthritis Therapeutics Drug Price by Type
        4.3.1 Global Psoriatic Arthritis Therapeutics Drug Price by Type (2017-2022)
        4.3.2 Global Psoriatic Arthritis Therapeutics Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Application
        5.1.1 Global Psoriatic Arthritis Therapeutics Drug Historical Sales by Application (2017-2022)
        5.1.2 Global Psoriatic Arthritis Therapeutics Drug Forecasted Sales by Application (2023-2028)
        5.1.3 Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2017-2028)
    5.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Application
        5.2.1 Global Psoriatic Arthritis Therapeutics Drug Historical Revenue by Application (2017-2022)
        5.2.2 Global Psoriatic Arthritis Therapeutics Drug Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application (2017-2028)
    5.3 Global Psoriatic Arthritis Therapeutics Drug Price by Application
        5.3.1 Global Psoriatic Arthritis Therapeutics Drug Price by Application (2017-2022)
        5.3.2 Global Psoriatic Arthritis Therapeutics Drug Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Psoriatic Arthritis Therapeutics Drug Market Size by Type
        6.1.1 North America Psoriatic Arthritis Therapeutics Drug Sales by Type (2017-2028)
        6.1.2 North America Psoriatic Arthritis Therapeutics Drug Revenue by Type (2017-2028)
    6.2 North America Psoriatic Arthritis Therapeutics Drug Market Size by Application
        6.2.1 North America Psoriatic Arthritis Therapeutics Drug Sales by Application (2017-2028)
        6.2.2 North America Psoriatic Arthritis Therapeutics Drug Revenue by Application (2017-2028)
    6.3 North America Psoriatic Arthritis Therapeutics Drug Market Size by Country
        6.3.1 North America Psoriatic Arthritis Therapeutics Drug Sales by Country (2017-2028)
        6.3.2 North America Psoriatic Arthritis Therapeutics Drug Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Psoriatic Arthritis Therapeutics Drug Market Size by Type
        7.1.1 Europe Psoriatic Arthritis Therapeutics Drug Sales by Type (2017-2028)
        7.1.2 Europe Psoriatic Arthritis Therapeutics Drug Revenue by Type (2017-2028)
    7.2 Europe Psoriatic Arthritis Therapeutics Drug Market Size by Application
        7.2.1 Europe Psoriatic Arthritis Therapeutics Drug Sales by Application (2017-2028)
        7.2.2 Europe Psoriatic Arthritis Therapeutics Drug Revenue by Application (2017-2028)
    7.3 Europe Psoriatic Arthritis Therapeutics Drug Market Size by Country
        7.3.1 Europe Psoriatic Arthritis Therapeutics Drug Sales by Country (2017-2028)
        7.3.2 Europe Psoriatic Arthritis Therapeutics Drug Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Psoriatic Arthritis Therapeutics Drug Market Size by Type
        8.1.1 Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales by Type (2017-2028)
        8.1.2 Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue by Type (2017-2028)
    8.2 Asia Pacific Psoriatic Arthritis Therapeutics Drug Market Size by Application
        8.2.1 Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales by Application (2017-2028)
        8.2.2 Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue by Application (2017-2028)
    8.3 Asia Pacific Psoriatic Arthritis Therapeutics Drug Market Size by Region
        8.3.1 Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales by Region (2017-2028)
        8.3.2 Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Psoriatic Arthritis Therapeutics Drug Market Size by Type
        9.1.1 Latin America Psoriatic Arthritis Therapeutics Drug Sales by Type (2017-2028)
        9.1.2 Latin America Psoriatic Arthritis Therapeutics Drug Revenue by Type (2017-2028)
    9.2 Latin America Psoriatic Arthritis Therapeutics Drug Market Size by Application
        9.2.1 Latin America Psoriatic Arthritis Therapeutics Drug Sales by Application (2017-2028)
        9.2.2 Latin America Psoriatic Arthritis Therapeutics Drug Revenue by Application (2017-2028)
    9.3 Latin America Psoriatic Arthritis Therapeutics Drug Market Size by Country
        9.3.1 Latin America Psoriatic Arthritis Therapeutics Drug Sales by Country (2017-2028)
        9.3.2 Latin America Psoriatic Arthritis Therapeutics Drug Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Market Size by Type
        10.1.1 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue by Type (2017-2028)
    10.2 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Market Size by Application
        10.2.1 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue by Application (2017-2028)
    10.3 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Market Size by Country
        10.3.1 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 AbbVie
        11.1.1 AbbVie Corporation Information
        11.1.2 AbbVie Overview
        11.1.3 AbbVie Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 AbbVie Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 AbbVie Recent Developments
    11.2 Janssen Biotech
        11.2.1 Janssen Biotech Corporation Information
        11.2.2 Janssen Biotech Overview
        11.2.3 Janssen Biotech Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Janssen Biotech Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Janssen Biotech Recent Developments
    11.3 Novartis
        11.3.1 Novartis Corporation Information
        11.3.2 Novartis Overview
        11.3.3 Novartis Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Novartis Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Novartis Recent Developments
    11.4 Amgen
        11.4.1 Amgen Corporation Information
        11.4.2 Amgen Overview
        11.4.3 Amgen Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Amgen Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Amgen Recent Developments
    11.5 CELGENE CORPORATION
        11.5.1 CELGENE CORPORATION Corporation Information
        11.5.2 CELGENE CORPORATION Overview
        11.5.3 CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 CELGENE CORPORATION Recent Developments
    11.6 Pfizer
        11.6.1 Pfizer Corporation Information
        11.6.2 Pfizer Overview
        11.6.3 Pfizer Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Pfizer Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Pfizer Recent Developments
    11.7 Eli Lilly
        11.7.1 Eli Lilly Corporation Information
        11.7.2 Eli Lilly Overview
        11.7.3 Eli Lilly Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Eli Lilly Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Eli Lilly Recent Developments
    11.8 UCB
        11.8.1 UCB Corporation Information
        11.8.2 UCB Overview
        11.8.3 UCB Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 UCB Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 UCB Recent Developments
    11.9 Biogen
        11.9.1 Biogen Corporation Information
        11.9.2 Biogen Overview
        11.9.3 Biogen Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Biogen Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Biogen Recent Developments
    11.10 Bristol-Myers Squibb
        11.10.1 Bristol-Myers Squibb Corporation Information
        11.10.2 Bristol-Myers Squibb Overview
        11.10.3 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Bristol-Myers Squibb Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Psoriatic Arthritis Therapeutics Drug Industry Chain Analysis
    12.2 Psoriatic Arthritis Therapeutics Drug Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Psoriatic Arthritis Therapeutics Drug Production Mode & Process
    12.4 Psoriatic Arthritis Therapeutics Drug Sales and Marketing
        12.4.1 Psoriatic Arthritis Therapeutics Drug Sales Channels
        12.4.2 Psoriatic Arthritis Therapeutics Drug Distributors
    12.5 Psoriatic Arthritis Therapeutics Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Psoriatic Arthritis Therapeutics Drug Industry Trends
    13.2 Psoriatic Arthritis Therapeutics Drug Market Drivers
    13.3 Psoriatic Arthritis Therapeutics Drug Market Challenges
    13.4 Psoriatic Arthritis Therapeutics Drug Market Restraints
14 Key Findings in The Global Psoriatic Arthritis Therapeutics Drug Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Psoriatic Arthritis Therapeutics Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of NF Inhibitors
    Table 3. Major Manufacturers of Interleukin Inhibitors
    Table 4. Major Manufacturers of PDE4 Inhibitors
    Table 5. Major Manufacturers of Others
    Table 6. Global Psoriatic Arthritis Therapeutics Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Psoriatic Arthritis Therapeutics Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Psoriatic Arthritis Therapeutics Drug Sales by Region (2017-2022) & (K Units)
    Table 9. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Region (2017-2022)
    Table 10. Global Psoriatic Arthritis Therapeutics Drug Sales by Region (2023-2028) & (K Units)
    Table 11. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Region (2023-2028)
    Table 12. Global Psoriatic Arthritis Therapeutics Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Region (2017-2022)
    Table 14. Global Psoriatic Arthritis Therapeutics Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Region (2023-2028)
    Table 16. Global Psoriatic Arthritis Therapeutics Drug Sales by Manufacturers (2017-2022) & (K Units)
    Table 17. Global Psoriatic Arthritis Therapeutics Drug Sales Share by Manufacturers (2017-2022)
    Table 18. Global Psoriatic Arthritis Therapeutics Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Psoriatic Arthritis Therapeutics Drug Revenue Share by Manufacturers (2017-2022)
    Table 20. Psoriatic Arthritis Therapeutics Drug Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 21. Global Psoriatic Arthritis Therapeutics Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Psoriatic Arthritis Therapeutics Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriatic Arthritis Therapeutics Drug as of 2021)
    Table 23. Psoriatic Arthritis Therapeutics Drug Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Psoriatic Arthritis Therapeutics Drug Product Offered
    Table 25. Date of Manufacturers Enter into Psoriatic Arthritis Therapeutics Drug Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Psoriatic Arthritis Therapeutics Drug Sales by Type (2017-2022) & (K Units)
    Table 28. Global Psoriatic Arthritis Therapeutics Drug Sales by Type (2023-2028) & (K Units)
    Table 29. Global Psoriatic Arthritis Therapeutics Drug Sales Share by Type (2017-2022)
    Table 30. Global Psoriatic Arthritis Therapeutics Drug Sales Share by Type (2023-2028)
    Table 31. Global Psoriatic Arthritis Therapeutics Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Psoriatic Arthritis Therapeutics Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Psoriatic Arthritis Therapeutics Drug Revenue Share by Type (2017-2022)
    Table 34. Global Psoriatic Arthritis Therapeutics Drug Revenue Share by Type (2023-2028)
    Table 35. Psoriatic Arthritis Therapeutics Drug Price by Type (2017-2022) & (USD/Unit)
    Table 36. Global Psoriatic Arthritis Therapeutics Drug Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 37. Global Psoriatic Arthritis Therapeutics Drug Sales by Application (2017-2022) & (K Units)
    Table 38. Global Psoriatic Arthritis Therapeutics Drug Sales by Application (2023-2028) & (K Units)
    Table 39. Global Psoriatic Arthritis Therapeutics Drug Sales Share by Application (2017-2022)
    Table 40. Global Psoriatic Arthritis Therapeutics Drug Sales Share by Application (2023-2028)
    Table 41. Global Psoriatic Arthritis Therapeutics Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Psoriatic Arthritis Therapeutics Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Psoriatic Arthritis Therapeutics Drug Revenue Share by Application (2017-2022)
    Table 44. Global Psoriatic Arthritis Therapeutics Drug Revenue Share by Application (2023-2028)
    Table 45. Psoriatic Arthritis Therapeutics Drug Price by Application (2017-2022) & (USD/Unit)
    Table 46. Global Psoriatic Arthritis Therapeutics Drug Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 47. North America Psoriatic Arthritis Therapeutics Drug Sales by Type (2017-2022) & (K Units)
    Table 48. North America Psoriatic Arthritis Therapeutics Drug Sales by Type (2023-2028) & (K Units)
    Table 49. North America Psoriatic Arthritis Therapeutics Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Psoriatic Arthritis Therapeutics Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Psoriatic Arthritis Therapeutics Drug Sales by Application (2017-2022) & (K Units)
    Table 52. North America Psoriatic Arthritis Therapeutics Drug Sales by Application (2023-2028) & (K Units)
    Table 53. North America Psoriatic Arthritis Therapeutics Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Psoriatic Arthritis Therapeutics Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Psoriatic Arthritis Therapeutics Drug Sales by Country (2017-2022) & (K Units)
    Table 56. North America Psoriatic Arthritis Therapeutics Drug Sales by Country (2023-2028) & (K Units)
    Table 57. North America Psoriatic Arthritis Therapeutics Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Psoriatic Arthritis Therapeutics Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Psoriatic Arthritis Therapeutics Drug Sales by Type (2017-2022) & (K Units)
    Table 60. Europe Psoriatic Arthritis Therapeutics Drug Sales by Type (2023-2028) & (K Units)
    Table 61. Europe Psoriatic Arthritis Therapeutics Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Psoriatic Arthritis Therapeutics Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Psoriatic Arthritis Therapeutics Drug Sales by Application (2017-2022) & (K Units)
    Table 64. Europe Psoriatic Arthritis Therapeutics Drug Sales by Application (2023-2028) & (K Units)
    Table 65. Europe Psoriatic Arthritis Therapeutics Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Psoriatic Arthritis Therapeutics Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Psoriatic Arthritis Therapeutics Drug Sales by Country (2017-2022) & (K Units)
    Table 68. Europe Psoriatic Arthritis Therapeutics Drug Sales by Country (2023-2028) & (K Units)
    Table 69. Europe Psoriatic Arthritis Therapeutics Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Psoriatic Arthritis Therapeutics Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales by Type (2017-2022) & (K Units)
    Table 72. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales by Type (2023-2028) & (K Units)
    Table 73. Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales by Application (2017-2022) & (K Units)
    Table 76. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales by Application (2023-2028) & (K Units)
    Table 77. Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales by Region (2017-2022) & (K Units)
    Table 80. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales by Region (2023-2028) & (K Units)
    Table 81. Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Psoriatic Arthritis Therapeutics Drug Sales by Type (2017-2022) & (K Units)
    Table 84. Latin America Psoriatic Arthritis Therapeutics Drug Sales by Type (2023-2028) & (K Units)
    Table 85. Latin America Psoriatic Arthritis Therapeutics Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Psoriatic Arthritis Therapeutics Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Psoriatic Arthritis Therapeutics Drug Sales by Application (2017-2022) & (K Units)
    Table 88. Latin America Psoriatic Arthritis Therapeutics Drug Sales by Application (2023-2028) & (K Units)
    Table 89. Latin America Psoriatic Arthritis Therapeutics Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Psoriatic Arthritis Therapeutics Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Psoriatic Arthritis Therapeutics Drug Sales by Country (2017-2022) & (K Units)
    Table 92. Latin America Psoriatic Arthritis Therapeutics Drug Sales by Country (2023-2028) & (K Units)
    Table 93. Latin America Psoriatic Arthritis Therapeutics Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Psoriatic Arthritis Therapeutics Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales by Type (2017-2022) & (K Units)
    Table 96. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales by Type (2023-2028) & (K Units)
    Table 97. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales by Application (2017-2022) & (K Units)
    Table 100. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales by Application (2023-2028) & (K Units)
    Table 101. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales by Country (2017-2022) & (K Units)
    Table 104. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales by Country (2023-2028) & (K Units)
    Table 105. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 107. AbbVie Corporation Information
    Table 108. AbbVie Description and Major Businesses
    Table 109. AbbVie Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 110. AbbVie Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. AbbVie Recent Developments
    Table 112. Janssen Biotech Corporation Information
    Table 113. Janssen Biotech Description and Major Businesses
    Table 114. Janssen Biotech Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 115. Janssen Biotech Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Janssen Biotech Recent Developments
    Table 117. Novartis Corporation Information
    Table 118. Novartis Description and Major Businesses
    Table 119. Novartis Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 120. Novartis Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Novartis Recent Developments
    Table 122. Amgen Corporation Information
    Table 123. Amgen Description and Major Businesses
    Table 124. Amgen Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 125. Amgen Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Amgen Recent Developments
    Table 127. CELGENE CORPORATION Corporation Information
    Table 128. CELGENE CORPORATION Description and Major Businesses
    Table 129. CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 130. CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. CELGENE CORPORATION Recent Developments
    Table 132. Pfizer Corporation Information
    Table 133. Pfizer Description and Major Businesses
    Table 134. Pfizer Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 135. Pfizer Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Pfizer Recent Developments
    Table 137. Eli Lilly Corporation Information
    Table 138. Eli Lilly Description and Major Businesses
    Table 139. Eli Lilly Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 140. Eli Lilly Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Eli Lilly Recent Developments
    Table 142. UCB Corporation Information
    Table 143. UCB Description and Major Businesses
    Table 144. UCB Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 145. UCB Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. UCB Recent Developments
    Table 147. Biogen Corporation Information
    Table 148. Biogen Description and Major Businesses
    Table 149. Biogen Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 150. Biogen Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Biogen Recent Developments
    Table 152. Bristol-Myers Squibb Corporation Information
    Table 153. Bristol-Myers Squibb Description and Major Businesses
    Table 154. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 155. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Bristol-Myers Squibb Recent Developments
    Table 157. Key Raw Materials Lists
    Table 158. Raw Materials Key Suppliers Lists
    Table 159. Psoriatic Arthritis Therapeutics Drug Distributors List
    Table 160. Psoriatic Arthritis Therapeutics Drug Customers List
    Table 161. Psoriatic Arthritis Therapeutics Drug Market Trends
    Table 162. Psoriatic Arthritis Therapeutics Drug Market Drivers
    Table 163. Psoriatic Arthritis Therapeutics Drug Market Challenges
    Table 164. Psoriatic Arthritis Therapeutics Drug Market Restraints
    Table 165. Research Programs/Design for This Report
    Table 166. Key Data Information from Secondary Sources
    Table 167. Key Data Information from Primary Sources
List of Figures
    Figure 1. Psoriatic Arthritis Therapeutics Drug Product Picture
    Figure 3. Global Psoriatic Arthritis Therapeutics Drug Market Share by Type in 2021 & 2028
    Figure 3. NF Inhibitors Product Picture
    Figure 4. Interleukin Inhibitors Product Picture
    Figure 5. PDE4 Inhibitors Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Psoriatic Arthritis Therapeutics Drug Market Share by Application in 2021 & 2028
    Figure 8. Hospital Pharmacies
    Figure 9. Retail Pharmacies
    Figure 10. Online Pharmacies
    Figure 11. Psoriatic Arthritis Therapeutics Drug Report Years Considered
    Figure 12. Global Psoriatic Arthritis Therapeutics Drug Sales 2017-2028 (K Units)
    Figure 13. Global Psoriatic Arthritis Therapeutics Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Psoriatic Arthritis Therapeutics Drug Revenue 2017-2028 (US$ Million)
    Figure 15. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Region (2017-2022)
    Figure 17. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Region (2023-2028)
    Figure 18. North America Psoriatic Arthritis Therapeutics Drug Sales YoY (2017-2028) & (K Units)
    Figure 19. North America Psoriatic Arthritis Therapeutics Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Psoriatic Arthritis Therapeutics Drug Sales YoY (2017-2028) & (K Units)
    Figure 21. Europe Psoriatic Arthritis Therapeutics Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Psoriatic Arthritis Therapeutics Drug Sales YoY (2017-2028) & (K Units)
    Figure 23. Asia-Pacific Psoriatic Arthritis Therapeutics Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Psoriatic Arthritis Therapeutics Drug Sales YoY (2017-2028) & (K Units)
    Figure 25. Latin America Psoriatic Arthritis Therapeutics Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales YoY (2017-2028) & (K Units)
    Figure 27. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Psoriatic Arthritis Therapeutics Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Psoriatic Arthritis Therapeutics Drug in the World: Market Share by Psoriatic Arthritis Therapeutics Drug Revenue in 2021
    Figure 30. Global Psoriatic Arthritis Therapeutics Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2017-2028)
    Figure 32. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2017-2028)
    Figure 33. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2017-2028)
    Figure 34. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application (2017-2028)
    Figure 35. North America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2017-2028)
    Figure 36. North America Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2017-2028)
    Figure 37. North America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2017-2028)
    Figure 38. North America Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application (2017-2028)
    Figure 39. North America Psoriatic Arthritis Therapeutics Drug Sales Share by Country (2017-2028)
    Figure 40. North America Psoriatic Arthritis Therapeutics Drug Revenue Share by Country (2017-2028)
    Figure 41. U.S. Psoriatic Arthritis Therapeutics Drug Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Psoriatic Arthritis Therapeutics Drug Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2017-2028)
    Figure 44. Europe Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2017-2028)
    Figure 46. Europe Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Psoriatic Arthritis Therapeutics Drug Sales Share by Country (2017-2028)
    Figure 48. Europe Psoriatic Arthritis Therapeutics Drug Revenue Share by Country (2017-2028)
    Figure 49. Germany Psoriatic Arthritis Therapeutics Drug Revenue (2017-2028) & (US$ Million)
    Figure 50. France Psoriatic Arthritis Therapeutics Drug Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Psoriatic Arthritis Therapeutics Drug Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Psoriatic Arthritis Therapeutics Drug Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Psoriatic Arthritis Therapeutics Drug Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue Share by Region (2017-2028)
    Figure 60. China Psoriatic Arthritis Therapeutics Drug Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Psoriatic Arthritis Therapeutics Drug Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Psoriatic Arthritis Therapeutics Drug Revenue (2017-2028) & (US$ Million)
    Figure 63. India Psoriatic Arthritis Therapeutics Drug Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Psoriatic Arthritis Therapeutics Drug Revenue (2017-2028) & (US$ Million)
    Figure 65. Taiwan Psoriatic Arthritis Therapeutics Drug Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Psoriatic Arthritis Therapeutics Drug Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Psoriatic Arthritis Therapeutics Drug Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Psoriatic Arthritis Therapeutics Drug Revenue (2017-2028) & (US$ Million)
    Figure 69. Philippines Psoriatic Arthritis Therapeutics Drug Revenue (2017-2028) & (US$ Million)
    Figure 70. Latin America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2017-2028)
    Figure 71. Latin America Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2017-2028)
    Figure 72. Latin America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2017-2028)
    Figure 73. Latin America Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application (2017-2028)
    Figure 74. Latin America Psoriatic Arthritis Therapeutics Drug Sales Share by Country (2017-2028)
    Figure 75. Latin America Psoriatic Arthritis Therapeutics Drug Revenue Share by Country (2017-2028)
    Figure 76. Mexico Psoriatic Arthritis Therapeutics Drug Revenue (2017-2028) & (US$ Million)
    Figure 77. Brazil Psoriatic Arthritis Therapeutics Drug Revenue (2017-2028) & (US$ Million)
    Figure 78. Argentina Psoriatic Arthritis Therapeutics Drug Revenue (2017-2028) & (US$ Million)
    Figure 79. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales Share by Country (2017-2028)
    Figure 84. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue Share by Country (2017-2028)
    Figure 85. Turkey Psoriatic Arthritis Therapeutics Drug Revenue (2017-2028) & (US$ Million)
    Figure 86. Saudi Arabia Psoriatic Arthritis Therapeutics Drug Revenue (2017-2028) & (US$ Million)
    Figure 87. U.A.E Psoriatic Arthritis Therapeutics Drug Revenue (2017-2028) & (US$ Million)
    Figure 88. Psoriatic Arthritis Therapeutics Drug Value Chain
    Figure 89. Psoriatic Arthritis Therapeutics Drug Production Process
    Figure 90. Channels of Distribution
    Figure 91. Distributors Profiles
    Figure 92. Bottom-up and Top-down Approaches for This Report
    Figure 93. Data Triangulation
    Figure 94. Key Executives Interviewed